These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19578014)

  • 21. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D inhibits angiogenesis in transgenic murine retinoblastoma.
    Shokravi MT; Marcus DM; Alroy J; Egan K; Saornil MA; Albert DM
    Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):83-7. PubMed ID: 7529753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of bevacizumab on the angiogenesis and growth of retinoblastoma.
    Lee SY; Kim DK; Cho JH; Koh JY; Yoon YH
    Arch Ophthalmol; 2008 Jul; 126(7):953-8. PubMed ID: 18625942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.
    Penn JS; Rajaratnam VS; Collier RJ; Clark AF
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):283-90. PubMed ID: 11133880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma.
    Schmack I; Hubbard GB; Kang SJ; Aaberg TM; Grossniklaus HE
    Am J Ophthalmol; 2006 Aug; 142(2):310-5. PubMed ID: 16876514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneous tumor vasculature in retinoblastoma: implications for vessel targeting therapy.
    Jockovich ME; Piña Y; Alegret A; Cebulla C; Feuer W; Murray TG
    Retina; 2008 Mar; 28(3 Suppl):S81-6. PubMed ID: 18317352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H; Eagle RC; Shields CL; Shields JA
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.
    Abramson DH; Frank CM; Dunkel IJ
    Ophthalmology; 1999 Oct; 106(10):1947-50. PubMed ID: 10519590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
    Kim JW; Yau JW; Moshfeghi D; Fishman M
    J Pediatr Ophthalmol Strabismus; 2010 May; 47 Online():e1-4. PubMed ID: 21214147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local carboplatin therapy in transgenic murine retinoblastoma.
    Harbour JW; Murray TG; Hamasaki D; Cicciarelli N; Hernández E; Smith B; Windle J; O'Brien JM
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1892-8. PubMed ID: 8759359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of celecoxib in human retinoblastoma cell lines and in a transgenic murine model of retinoblastoma.
    Tong CT; Howard SA; Shah HR; Van Quill KR; Lin ET; Grossniklaus HE; O'Brien JM
    Br J Ophthalmol; 2005 Sep; 89(9):1217-20. PubMed ID: 16113385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.
    Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B
    Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicity and dose-response studies of 1 alpha-hydroxyvitamin D2 in LH beta-Tag transgenic mice.
    Dawson DG; Gleiser J; Zimbric ML; Darjatmoko SR; Frisbie JC; Lokken JM; Lindstrom MJ; Audo I; Strugnell SA; Albert DM
    Trans Am Ophthalmol Soc; 2002; 100():125-9. PubMed ID: 12545685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
    Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA
    Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumors.
    Houston SK; Pina Y; Clarke J; Koru-Sengul T; Scott WK; Nathanson L; Schefler AC; Murray TG
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5359-68. PubMed ID: 21571674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles.
    Li Z; Guo Z; Chu D; Feng H; Zhang J; Zhu L; Li J
    Drug Deliv; 2020 Dec; 27(1):358-366. PubMed ID: 32091275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of action of the angiostatic cortisene anecortave acetate.
    Clark AF
    Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S26-34. PubMed ID: 17240253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model.
    Heijmen L; Ter Voert EG; Punt CJ; Heerschap A; Oyen WJ; Bussink J; Sweep CG; Laverman P; Span PN; de Geus-Oei LF; Boerman OC; van Laarhoven HW
    Contrast Media Mol Imaging; 2014; 9(3):237-45. PubMed ID: 24700751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Posterior juxtascleral injection of anecortave acetate: magnetic resonance and echographic imaging and localization in rabbit eyes.
    Jockovich ME; Murray TG; Clifford PD; Moshfeghi AA
    Retina; 2007 Feb; 27(2):247-52. PubMed ID: 17290209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.